You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
Title |
Allogeneic stem cell transplantation versus conventional therapy for advanced primary cutaneous T‐cell lymphoma
|
---|---|
Published in |
Cochrane database of systematic reviews, August 2013
|
DOI | 10.1002/14651858.cd008908.pub3 |
Pubmed ID | |
Authors |
Max Schlaak, Juliane Pickenhain, Sebastian Theurich, Nicole Skoetz, Michael von Bergwelt‐Baildon, Peter Kurschat |
Abstract |
Primary cutaneous T-cell lymphomas (CTCL) belong to the group of non-Hodgkin lymphomas and usually run an indolent course. However, some patients progress to advanced tumour or leukaemic stages. To date, there is no cure for those cases. In the last few years, several publications reported durable responses in some patients following allogeneic stem cell transplantation (alloSCT). This is an update of a Cochrane review first published in 2011 and updated in 2013. |
X Demographics
The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
Country | Count | As % |
---|---|---|
United Kingdom | 1 | 50% |
Unknown | 1 | 50% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Practitioners (doctors, other healthcare professionals) | 1 | 50% |
Members of the public | 1 | 50% |
Mendeley readers
The data shown below were compiled from readership statistics for 125 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
Germany | 1 | <1% |
Unknown | 124 | 99% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Master | 18 | 14% |
Student > Bachelor | 16 | 13% |
Researcher | 11 | 9% |
Student > Postgraduate | 10 | 8% |
Student > Ph. D. Student | 9 | 7% |
Other | 18 | 14% |
Unknown | 43 | 34% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 44 | 35% |
Psychology | 9 | 7% |
Nursing and Health Professions | 9 | 7% |
Agricultural and Biological Sciences | 8 | 6% |
Pharmacology, Toxicology and Pharmaceutical Science | 5 | 4% |
Other | 8 | 6% |
Unknown | 42 | 34% |
Attention Score in Context
This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 30 August 2013.
All research outputs
#16,783,081
of 25,457,297 outputs
Outputs from Cochrane database of systematic reviews
#10,370
of 11,499 outputs
Outputs of similar age
#129,544
of 212,370 outputs
Outputs of similar age from Cochrane database of systematic reviews
#200
of 229 outputs
Altmetric has tracked 25,457,297 research outputs across all sources so far. This one is in the 32nd percentile – i.e., 32% of other outputs scored the same or lower than it.
So far Altmetric has tracked 11,499 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 40.0. This one is in the 8th percentile – i.e., 8% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 212,370 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 37th percentile – i.e., 37% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 229 others from the same source and published within six weeks on either side of this one. This one is in the 12th percentile – i.e., 12% of its contemporaries scored the same or lower than it.